发明名称 ORALLY ACTIVE ANTIVIRAL COMPOUNDS
摘要 A compound represented by formula I Ar1-O-M-O-Ar2 I wherein Ar1 and Ar2 are independently substituted phenyl or substituted pyridinyl, the substituents on said phenyl or pyridinyl being independently selected from one, two or three of (C1-C10) alkyl, (C1-C10) alkoxy, halogen, carbamyl, dialkylcarbamyl, (C1-C10)-alkoxycarbonyl, oxazoyl, and (C1-C10) alkyl substituted by halogen, (C1-C10) alkoxy, hydroxy, or (C1-C10) alkoxycarbonyl; <CHEM> (C4-C8) alkylene, (C4-C8) alkenylene or (C4-C8)- alkynylene; O is oxygen; R min is (C1-C3) alkyl or H; A is oxygen or sulfur; Q is selected from hydrogen, halogen, nitro, (C1-C6) alkyl, (C1-C6) perhaloalkyl, (C1-C6) alkylthio (C1-C6) alkyl sulfonyl; the dotted lines in M-3 and M-4 between carbons 2, 3 and 4, and 5 and 6 mean that the bonds between carbons 2 and 3, and 3 and 4, and 5 and 6, may each be a single or double bond; n = 1 or 2 m = 1 or 2 p = 0 or 1 and or pharmaceutically acceptable salts thereof. as well as pharmaceutical compositions containing the compounds and the use of the compounds of formula I for preparation of a medicament for methods of treating or preventing viral infections, especially picornaviral infections, are disclosed.
申请公布号 ZA9204445(B) 申请公布日期 1993.02.24
申请号 ZA19920004445 申请日期 1992.06.17
申请人 SCHERING CORPORATION 发明人 VIYYOOR M. GIRIJAVALLABHAN;ASHIT K. GANGULY;RICHARD W. VERSACE;ANIL K. SAKSENA;PATRICK A. PINTO
分类号 A61K31/085;A61K31/09;A61K31/185;A61K31/235;A61K31/34;A61K31/341;A61K31/38;A61K31/381;A61K31/42;A61K31/421;A61P31/00;C07C43/205;C07C43/225;C07C43/23;C07C69/92;C07C205/38;C07C233/25;C07C255/54;C07C317/22;C07C323/19;C07D213/30;C07D213/65;C07D263/12;C07D263/14;C07D307/12;C07D307/28;C07D307/42;C07D333/16 主分类号 A61K31/085
代理机构 代理人
主权项
地址